Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-02
2000-02-15
Trinh, Ba K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549475, 549497, 549504, A61K 3134, C07D30720
Patent
active
060253924
ABSTRACT:
Substituted tetrahydrofuran analogs of F-series prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.
REFERENCES:
patent: 3883659 (1975-05-01), Vlattas
patent: 4088779 (1978-05-01), Vlattas
patent: 4133817 (1979-01-01), Lourens et al.
patent: 5574066 (1996-11-01), Chan et al.
Alm, "The Potential of Prostaglandin Derivatives in Glaucoma Therapy" Current Opinion in Ophthalmology 4(II):44-50 (1993).
Arndt et al., "Stereospecific Synthesis of Modified Prostaglandins Derived from Carbohydrates. Part 1." S. Afr. J. Chem. 34(4):121-127 (Jun. 1981).
Giuffre, "The Effects of Prostaglandin F.sub.2.alpha. in the Human Eye" Graefe's Arch Clin Exp Ophthalmol 222:139-141 (1985).
Hanessian et al., "Total Synthesis of 11-Oxaprostaglandin F.sub.2.alpha. and F.sub.2.beta." Carbohydrate Research 141:221-238 (1985).
Kerstetter et al., "Prostaglandin F.sub.2.alpha. -1-Isopropylester Lowers Intracular Pressure Without Decreasing Aqueous Humor Flow" American Journal of Ophthalmology 105:30-34 (1988).
Lourens et al., "The Novel Stereospecific Synthesis of 11-Oxaprostaglandin F.sub.2.alpha." Tetrahedron Letters, No. 43:3719-3722 Pergamon Press XP000644760 (1975).
Nakajima et al., "Effects of Prostaglandin D.sub.2 and its Analogue, BW245C, on Intraocular Pressure in Humans" Graefe's Arch Clin Exp Ophthalmol 229:411-413 (1991).
Thiem et al., "Synthese von Oxaprostaglandinen aus 1,4:3,6-Dianhydro-D-sorbit" Liebigs Ann. Chem. 2151:2164 XP000644761 (1985).
Thierauch et al., "Prostaglandins and Their Receptors: II. Receptor Structure and Signal Transduction" Journal of Hypertension 12:1-5 (1994).
Verdoorn et al., "Synthesis of Methyl (5Z,13E)(15S)-9.alpha.-acetoxy-15-hydroxy-17-(3-trifluoromethylphenyl)-11- oxa-18,19,20-trinorprosta-5,13-dienoate" S. Afr. Tydskr. Chem. 40(2):134-138 (1987).
Vlattas et al., "Synthesis of 9-Oxaprostaglandins" Tetrahedron Letters No. 51/52:4455-4458, Pergamon Press, 1974.
Vlattas et al., "Synthesis of 11-Oxaprostaglandins" Tetrahedron Letters No. 51/52:4451-4454, XP000644759, Pergamon Press, 1974.
Hellberg Mark R.
Klimko Peter G.
Sallee Verney L.
Selliah Robert D.
Zinke Paul W.
Alcon Laboratories Inc.
Copeland Barry L.
Trinh Ba K.
LandOfFree
substituted tetrahydrofuran analogs of prostaglandins as ocular does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with substituted tetrahydrofuran analogs of prostaglandins as ocular , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and substituted tetrahydrofuran analogs of prostaglandins as ocular will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906437